concept

NLRP3 INFLAMMASOME ACTIVATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NLRP3 INFLAMMASOME ACTIVATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

60Connections

10Hypotheses

3Analyses

15Outgoing

45Incoming

20Experiments

3Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	NLRP3 INFLAMMASOME ACTIVATION

Pathway Diagram

graph TD
    NLRP3_INFLAMMASOME_ACTIVATION["NLRP3 INFLAMMASOME ACTIVATION"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"mediates"| Pyroptosis["Pyroptosis"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL_1_["IL-1Beta"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL_18["IL-18"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL1B["IL1B"]
    NLRP3_INFLAMMASOME_ACTIVATION -->|"activates"| IL18["IL18"]
    USP22["USP22"] -->|"inhibits"| NLRP3_INFLAMMASOME_ACTIVATION
    TREM2_Deficiency["TREM2 Deficiency"] -->|"causes"| NLRP3_INFLAMMASOME_ACTIVATION
    USP5["USP5"] -->|"inhibits"| NLRP3_INFLAMMASOME_ACTIVATION
    TREM2["TREM2"] -->|"regulates"| NLRP3_INFLAMMASOME_ACTIVATION
    NEK7["NEK7"] -->|"promotes"| NLRP3_INFLAMMASOME_ACTIVATION
    Autophagic_Degradation["Autophagic Degradation"] -->|"inhibits"| NLRP3_INFLAMMASOME_ACTIVATION
    Lps["Lps"] -->|"activates"| NLRP3_INFLAMMASOME_ACTIVATION
    Atp["Atp"] -->|"activates"| NLRP3_INFLAMMASOME_ACTIVATION

Outgoing (15)

Target	Relation	Type	Str
Neuroinflammation	mediates	process	0.92
Neurodegenerative Disorders	contributes_to	disease	0.90
IL-1Β	activates	protein	0.90
IL-18	activates	protein	0.90
Neuroinflammation	contributes_to	process	0.90
Neurodegeneration	contributes_to	disease	0.90
inflammation	drives	process	0.90
Pyroptosis	mediates	process	0.90
IL-1Β	associated_with	protein	0.90
IL-18	associated_with	protein	0.90
Alzheimer disease	associated_with	disease	0.90
IL1B	activates	protein	0.90
IL18	activates	protein	0.90
Renal Tubular Epithelial Cell Apoptosis	mediates	phenotype	0.85
Alzheimer's disease pathogenesis	causes	disease	0.70

Incoming (45)

Source	Relation	Type	Str
TREM2 Deficiency	associated_with	mechanism	0.95
TREM2 Deficiency	causes	mechanism	0.95
TREM2	regulates	gene	0.95
USP22	inhibits	protein	0.95
NEK7	promotes	protein	0.94
TLR2 inhibition	suppresses	process	0.92
cGAS-STING Pathway	activates	pathway	0.90
32958021	reduces AD pathology by inhibiting	paper	0.90
31284572	trigger	paper	0.90
32958021	inhibits	paper	0.90
Autophagic Degradation	inhibits	process	0.90
Lps	activates	compound	0.90
Atp	activates	compound	0.90
38989642	results in	paper	0.90
38989642	inhibit	paper	0.90
Alzheimer'S	associated_with	disease	0.90
STING Activation	activates	mechanism	0.90
Hesperetin	inhibits	compound	0.90
Autophagy	inhibits	process	0.88
α-Synuclein	activates	protein	0.85
Mitochondrial ROS	activates	biomarker	0.85
Lps	associated_with	compound	0.85
cGAS-STING pathway	regulates	pathway	0.85
Microglia	mediates	cell_type	0.85
ATG5	mediates	protein	0.85
Mitophagy	inhibits	process	0.85
Nigericin	activates	compound	0.85
NOD-Like Receptor Signaling Pathway	mediates	pathway	0.85
Complement Pathway	interacts_with	pathway	0.82
PYCARD	involved_in	gene	0.80
Ubiquitination	regulates	process	0.80
TREM2	inhibits	gene	0.80
AMPK	associated_with	protein	0.80
CSF1R modulators	inhibits	drug	0.75
AMPK	regulates	gene	0.75
Lysosomal membrane permeabilization	causes	mechanism	0.70
Galectin-3 deletion	inhibits	gene	0.70
31284572	regulate	paper	0.60
Acid sphingomyelinase	regulates	protein	0.60
38989642	inhibits	paper	0.60
SREBF2	regulates	gene	0.60
NLRP3	participates_in	gene	0.58
CASP1	participates_in	gene	0.58
IL1B	participates_in	gene	0.58
PYCARD	participates_in	gene	0.58

Targeting Hypotheses (10)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic
NLRP3/Mitophagy Coupling Modulation	0.681	Neuroinflammation	Immune atlas neuroinflammation analysis
Astrocyte-Microglia Communication Rebalancing via Cytokine M	0.655	neurodegeneration	Which cell types show the most significa
Microbial Inflammasome Priming Prevention	0.653	neurodegeneration	What are the mechanisms by which gut mic
Peripheral-to-Central Inflammation Circuit Breaker	0.626	-	Blood-brain barrier tight junction disru

Galectin-3 deletion attenuates NLRP3 inflammasome activation	0.625	neuroscience	Lysosomal dysfunction and cathepsin leak
Selective cathepsin B inhibition prevents cathepsin leakage-	0.620	neuroscience	Lysosomal dysfunction and cathepsin leak
Cardiovascular-Neuroinflammation Crosstalk Interruption	0.587	Alzheimer's disease	Neuroinflammation and microglial priming
NLRP3 Inflammasome Blockade as Upstream Intervention to Prev	0.566	neurodegeneration	Why have numerous phase 3 clinical trial
Circulating hs-CRP as Disease-Modifying Target via Astrocyti	0.380	immunomics	Systemic immune profiling in neurodegene

Mentioning Analyses (3)

Scientific analyses that reference this entity

What are the optimal temporal windows for TREM2 inhibition vs activation in Alzh

neurodegeneration | 2026-04-11 | 0 hypotheses

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

neuroscience | 2026-04-04 | 7 hypotheses Top: 0.679

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.907

Experiments (20)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Molecular characterization of RBG-NLRP3 binding interaction	exploratory	atherosclerosis	0.900	0.00	purified proteins and molecula	proposed	N/A
Leukocyte gene expression analysis in COVID-19 patients	exploratory	COVID-19	0.900	0.00	human leukocytes from COVID-19	proposed	N/A
LPS-induced mouse model of depression with synaptic loss analysis	validation	depression	0.900	0.00	LPS-treated mice	proposed	N/A
Network pharmacology analysis of QTJD active compounds and pathways	exploratory	Mycoplasma pneumoniae pneumoni	0.900	0.00	computational network analysis	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke, Atheroscleros	0.900	0.00	Human genetic association data	proposed	N/A
Bidirectional Mendelian randomization analysis of C1Q and ischemic str	exploratory	Ischemic stroke (large artery	0.900	0.00	human genetic data	proposed	N/A
Cerebrovascular function analysis in CD2AP mutant mice	validation	Alzheimer's disease	0.900	0.00	mice	proposed	N/A
RBG effects on macrophage polarization and foam cell formation	exploratory	atherosclerosis	0.850	0.00	primary macrophages	proposed	N/A
C1q neutralizing antibody intervention in depression model	validation	depression	0.850	0.00	LPS-treated mice with C1q anti	proposed	N/A
Transcriptomic analysis of RBG effects on inflammatory gene expression	exploratory	atherosclerosis	0.800	0.00	ApoE-/- mice and cell cultures	proposed	N/A
Cell-cell interaction analysis of perivascular-microglial crosstalk	exploratory	Alzheimer's disease	0.800	0.00	AD mouse models	proposed	N/A
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe	clinical	Neurodegeneration	0.400	0.50	in_silico	proposed	$180,000
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiation Mechanis	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Antiviral Therapy Trial for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Experiment: Autoimmune Hypothesis Testing in AD	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Microbiome-Gut Barrier Signatures in ALS — Experiment Design	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism and inter	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for S [PMID:41114949]	Ding YN, Li MQ, Ding PT, Wang P, Guan PP	Nano letters	2026	1
Systemic inflammation as a central player in the initiation and development of A [PMID:40841660]	Bayraktaroglu I, Ortí-Casañ N, Van Dam D	Immunity & ageing : I & A	2025	1
Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibi [PMID:40050873]	Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding	Journal of nanobiotechnology	2025	1
Interactions between antidiabetes medications and heart-brain axis. [PMID:39639832]	Ong LT, Sia CH	Current opinion in endocrinolo	2025	1
The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Rev [PMID:40507911]	Popa E, Popa AE, Poroch M, Poroch V, Ung	International journal of molec	2025	1
USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent au [PMID:35900990]	["Di Q", "Zhao X", "Tang H", "Li X", "Xi	Autophagy	2023	1
USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradatio [PMID:34486483]	["Cai B", "Zhao J", "Zhang Y", "Liu Y",	Autophagy	2022	1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877]	Waghmare A, Rahangdale S, Khare K, Taksa	Molecular and cellular neurosc	2026	0
The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peri [PMID:41569436]	Gopalakrishna PK, Che Mohd Nassir CMN, A	Cellular and molecular neurobi	2026	0
Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter [PMID:41687275]	Otálora-Alcaraz A, Sun MC, Hofman N, Cos	Multiple sclerosis and related	2026	0
NLRP3 Inflammasome and Polycystic Ovary Syndrome (PCOS): A Novel Profile in Adip [PMID:41596350]	Alenezi SA, Alshammari K, Khan R, Amer S	International journal of molec	2026	0
Exploring the Role of Microglial Cells in the Gut-Brain Axis Communication: A Sy [PMID:40662222]	Ortiz-Samur NS, Vijaya AK, Burokas A, Me	Journal of neurochemistry	2025	0
Sepsis and the Liver. [PMID:41439929]	["Geladari E", "Kalergi A", "Evangelopou	Diseases (Basel, Switzerland)	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	Int J Mol Sci	2025	0
Molecular links between inflammatory bowel disease and Alzheimer's disease throu [PMID:41480321]	Durairajan SSK, Singh AK, Sulaiman SM, P	World journal of gastroenterol	2025	0
Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS sy [PMID:40784090]	["Elbadry M", "Mabed M"]	Current research in translatio	2025	0
Δ9-Tetrahydrocannabinol and cannabidiol selectively suppress toll-like receptor [PMID:40553974]	Sermet S, Finn BM, Crawford RB, Kaminski	The Journal of pharmacology an	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	International journal of molec	2025	0
The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mou [PMID:39616735]	["Li S", "Withaar C", "Rodrigues P", "Zi	Biomedicine & pharmacotherapy	2024	0

Debates (3)

Multi-agent debates referencing this entity

Lysosomal membrane permeabilization releasing cathepsins triggers NLRP3 inflamma

closed · Rounds: 4 · Score: 0.76 · 2026-04-22

The debate proposed biphasic TREM2 modulation but couldn't define when to switch

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

What are the mechanisms underlying what are the mechanisms by which gut microbio

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning NLRP3 INFLAMMASOME ACTIVATION in their description or question text

Galectin-3 deletion attenuates NLRP3 inflammasome activation downstream of lysos

Score: 0.625 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** Galectin-3 (LGALS3) functions as a critical molecular sensor and platform orchest

Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 infla

Score: 0.620 · neuroscience · 2026-04-22

## Mechanistic Overview Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 inflammasome activati

Cardiovascular-Neuroinflammation Crosstalk Interruption

Score: 0.587 · Alzheimer's disease · 2026-04-04

# Cardiovascular-Neuroinflammation Crosstalk Interruption: Targeting Shared Inflammatory Mediators in Neurodegeneratio

NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificati

Score: 0.566 · neurodegeneration · 2026-04-16

## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t

Circulating hs-CRP as Disease-Modifying Target via Astrocytic NLRP3 Inflammasome

Score: 0.380 · immunomics · 2026-04-27

Elevated circulating high-sensitivity C-reactive protein (hs-CRP) serves as a disease-modifying target through direct ac